Lars Blomquist
Impact in
- Genetics top 2%
- Inflammatory Bowel Disease
- Gastroenterology top 5%
- Celiac Disease Research and Management
Papers in
- Genetics 6
- Inflammatory Bowel Disease 4
- Digestive system and related health 2
-
- Microscopic Colitis 3
- Co-authors
- Per M. Hellström (4 shared papers)Per Karlén (2 shared papers)Anders Magnuson (2 shared papers)Hans Verbaan (2 shared papers)Erik Hertervig (2 shared papers)Christer Grännö (2 shared papers)M. Vilien (2 shared papers)Magnus Ström (2 shared papers)
In The Last Decade
Lars Blomquist
19 papers receiving 1.0k citations
Lars Blomquist's Hit Papers
Peers
Comparison fields: 5 of 74
- Genetics 739
- Gastroenterology 75
- Epidemiology 373
- Hepatology 56
- Pharmaceutical Science 29
Countries citing papers authored by Lars Blomquist
This map shows the geographic impact of Lars Blomquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Blomquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Blomquist more than expected).
Fields of papers citing papers by Lars Blomquist
This network shows the impact of papers produced by Lars Blomquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Blomquist. The network helps show where Lars Blomquist may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Blomquist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study Hit paper breakdown → | 2005 | 812 |
| 2 | 1998 | 55 | |
| 3 | 1977 | 39 | |
| 4 | 2013 | 29 | |
| 5 | 2002 | 27 | |
| 6 | 1982 | 17 | |
| 7 | A 2-year follow-up of the swedish-danish Infliximab/Placebo trial in steroid resistant acute ulcerative colitis | 2007 | 14 |
| 8 | 1975 | 13 | |
| 9 | 1968 | 11 | |
| 10 | 1994 | 11 | |
| 11 | 1986 | 9 | |
| 12 | 1993 | 8 | |
| 13 | 2008 | 7 | |
| 14 | 2008 | 6 | |
| 15 | 1991 | 4 | |
| 16 | 1969 | 4 | |
| 17 | 1968 | 3 | |
| 18 | [Scintigraphic assessment of the small intestine transit. Diagnostic investigation of dysmotility with 99mTc-HIDA]. | 2002 | 2 |
| 19 | 1984 | 1 |
About Lars Blomquist
Lars Blomquist is a scholar working on Genetics, Epidemiology, Molecular Biology, Surgery and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (4 papers), Insect and Pesticide Research (3 papers), Microscopic Colitis (3 papers), Gastroesophageal reflux and treatments (2 papers), Liver Diseases and Immunity (2 papers), Digestive system and related health (2 papers), Alcohol Consumption and Health Effects (2 papers) and Neuropeptides and Animal Physiology (2 papers). The work is most often cited by research in Genetics (739 citations), Gastroenterology (75 citations), Epidemiology (373 citations), Hepatology (56 citations) and Pharmaceutical Science (29 citations). Lars Blomquist has collaborated with scholars based in Sweden, Italy and Norway. Frequent co-authors include Per M. Hellström, Per Karlén, Anders Magnuson, Hans Verbaan, Erik Hertervig, Christer Grännö, M. Vilien, Magnus Ström, Åke Danielsson and Ingalill Friis–Liby. Their work appears in journals such as Gastroenterology, European Journal of Gastroenterology & Hepatology, Scandinavian Journal of Gastroenterology, Alcohol and Alcoholism and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.